Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verrica Pharmaceuticals (VRCA) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to -$1.9 million.

  • Verrica Pharmaceuticals' Non Operating Income rose 1182.75% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.6 million, marking a year-over-year decrease of 3083.31%. This contributed to the annual value of -$10.7 million for FY2024, which is 76245.95% down from last year.
  • Latest data reveals that Verrica Pharmaceuticals reported Non Operating Income of -$1.9 million as of Q3 2025, which was up 1182.75% from -$1.3 million recorded in Q2 2025.
  • Verrica Pharmaceuticals' Non Operating Income's 5-year high stood at $626000.0 during Q2 2023, with a 5-year trough of -$4.8 million in Q4 2024.
  • For the 5-year period, Verrica Pharmaceuticals' Non Operating Income averaged around -$1.3 million, with its median value being -$1.1 million (2021).
  • Examining YoY changes over the last 5 years, Verrica Pharmaceuticals' Non Operating Income showed a top increase of 15978.99% in 2023 and a maximum decrease of 62974.91% in 2023.
  • Verrica Pharmaceuticals' Non Operating Income (Quarter) stood at -$1.1 million in 2021, then skyrocketed by 126.07% to $279000.0 in 2022, then tumbled by 629.75% to -$1.5 million in 2023, then plummeted by 224.22% to -$4.8 million in 2024, then surged by 60.33% to -$1.9 million in 2025.
  • Its Non Operating Income stands at -$1.9 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.6 million for Q1 2025.